{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:55:12Z","timestamp":1765976112886,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalsofvascularsurgery.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.avsg.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T04:45:44Z","timestamp":1471927544000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Kenneth","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brant W.","family":"Ullery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus R.","family":"Kret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-7792","authenticated-orcid":false,"given":"Jason T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2016.08.006_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/vhrm.2007.3.2.229","article-title":"Epidemiology, classification, and modifiable risk factors of peripheral arterial disease","volume":"3","author":"Shammas","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2016.08.006_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jvs.2006.04.054","article-title":"Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency","volume":"44","author":"Pereira","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib3","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.106.621391","article-title":"Endovascular therapies for peripheral arterial disease: an evidence-based review","volume":"116","author":"White","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2016.08.006_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrcardio.2011.81","article-title":"Peripheral artery disease. Part 2: medical and endovascular treatment","volume":"8","author":"Weinberg","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.avsg.2016.08.006_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiol.2211010039","article-title":"Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis","volume":"221","author":"Muradin","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.avsg.2016.08.006_bib6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jvs.2014.12.062","article-title":"Safety and efficacy of antiplatelet\/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease","volume":"61","author":"Ullery","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib7","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2016.08.006_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2016.08.006_bib9","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2016.08.006_bib10","first-page":"82","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"26","author":"Norgren","year":"2007","journal-title":"Int Angiol"},{"key":"10.1016\/j.avsg.2016.08.006_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on Wound, Ischemia, and foot Infection (WIfI)","volume":"59","author":"Mills","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcin.2015.03.022","article-title":"1-Year results of the ZEPHYR registry (Zilver PTX for the femoral artery and proximal popliteal artery)","volume":"8","author":"Iida","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2016.08.006_bib13","first-page":"115","article-title":"The Zilver(R) PTX(R) Single Arm Study: 12-month results from the TASC C\/D lesion subgroup","volume":"54","author":"Bosiers","year":"2013","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.avsg.2016.08.006_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcin.2012.12.118","article-title":"Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents","volume":"6","author":"Zeller","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2016.08.006_bib15","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2016.08.006_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jvs.2012.03.010","article-title":"Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease","volume":"56","author":"Johnston","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcin.2015.07.005","article-title":"3-Year outcomes of the OLIVE registry, a prospective multicenter study of patients with critical limb ischemia","volume":"8","author":"Iida","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2016.08.006_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jvs.2015.06.203","article-title":"Outcomes of lower extremity revascularization among the hemodialysis-dependent","volume":"62","author":"Fallon","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2016.08.006_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7133\/jca.13-00044","article-title":"Long-term results of treatment for critical limb ischemia","volume":"54","author":"Miyahara","year":"2014","journal-title":"J Jpn Coll Angiol"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509616306586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509616306586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T22:51:53Z","timestamp":1536447113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509616306586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"alternative-id":["S0890509616306586"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2016.08.006","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}